Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOn November 13, 2024, Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company focusing on innovative therapies for rare cardiopulmonary diseases,
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Liquidia’s 8K filing here. About Liquidia (Get Free Report) Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates […]
16 Nov 21:02 · The Markets Daily